Question...in your opinion, is this "license agreement" like a contract? Or is it a value-added agreement? If Amarantus generates interest in it's portfolio, by a big pharma for instance, can the terms be adjusted to reflect say a buyout whereby the "package" is on the block so-to-speak for the entire portfolio? Or is it a flat rate affair as per, what I gather, the agreement? I am curious that's all Warp...